The Global Antibiotic Research and Development Partnership (GARDP) brings together public and private partners to accelerate the development and global availability of new antibiotics to treat the most challenging drug-resistant bacterial infections. Established in 2016, GARDP's recently launched strategy sets out its ambitious aim to deliver five new treatments by 2025, focusing on sexually transmitted infections, sepsis in newborns, and infections in hospitalized adults and children.
机构:
Eurofins Global Cent Lab, Chantilly, VA USAAntiinfect Consulting LLC, Stonington, CT USA
Sahm, Dan
Opiela, Carol
论文数: 0引用数: 0
h-index: 0
机构:
Eurofins Global Cent Lab, Chantilly, VA USAAntiinfect Consulting LLC, Stonington, CT USA
Opiela, Carol
Spellbergc, Brad
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif Los Angeles, David Geffen Sch Med, Harbor UCLA Med Ctr, Div Gen Internal Med,Los Angeles Biomed Res Inst, Los Angeles, CA 90095 USAAntiinfect Consulting LLC, Stonington, CT USA